Groupe Danone SA Stock Rating Reaffirmed by BNP Paribas (BN)

Groupe Danone SA (EPA: BN)‘s stock had its “outperform” rating reiterated by stock analysts at BNP Paribas in a report issued on Thursday, Analyst Ratings Network reports. They currently have a €70.00 ($90.91) price target on the stock.

Shares of Groupe Danone SA (EPA: BN) traded down 0.84% during mid-day trading on Thursday, hitting €56.66. Groupe Danone SA has a one year low of €45.605 and a one year high of €60.00. The stock’s 50-day moving average is currently €48.70. The company has a market cap of €33.658 billion and a P/E ratio of 20.63.

A number of other firms have also recently commented on BN. Analysts at Canaccord Genuity reiterated a “sell” rating on shares of Groupe Danone SA in a research note to investors on Wednesday, June 5th. They now have a €45.00 ($58.44) price target on the stock. Separately, analysts at JPMorgan Chase reiterated a “neutral” rating on shares of Groupe Danone SA in a research note to investors on Wednesday, May 29th. Finally, analysts at Sanford C. Bernstein reiterated a “market perform” rating on shares of Groupe Danone SA in a research note to investors on Monday, May 20th. They now have a €58.00 ($75.32) price target on the stock.

Three analysts have rated the stock with a sell rating, eight have assigned a hold rating and seven have issued a buy rating to the company’s stock. Groupe Danone SA has an average rating of “Hold” and an average price target of €54.84 ($71.22).

Groupe Danone is a food company that primarily produces fresh milk products, baby foods, biscuits, cereal products and medical nutrition products.

Latest News

Andeavor Logistics LP  Receives $50.67 Consensus Target Price from Analysts
Andeavor Logistics LP Receives $50.67 Consensus Target Price from Analysts
Somewhat Positive Media Coverage Somewhat Unlikely to Impact Gemphire Therapeutics  Stock Price
Somewhat Positive Media Coverage Somewhat Unlikely to Impact Gemphire Therapeutics Stock Price
Aviat Networks  Given Daily Media Impact Rating of 0.09
Aviat Networks Given Daily Media Impact Rating of 0.09
Papa Murphy’s  Getting Somewhat Positive News Coverage, Report Shows
Papa Murphy’s Getting Somewhat Positive News Coverage, Report Shows
EXFO  Given Average Recommendation of “Hold” by Brokerages
EXFO Given Average Recommendation of “Hold” by Brokerages
Brokerages Set ANI Pharmaceuticals Inc Common Stock  Price Target at $79.00
Brokerages Set ANI Pharmaceuticals Inc Common Stock Price Target at $79.00


© 2006-2018 Ticker Report. Google+.